Why Singapore?
Singapore’s strategic location in the heart of Asia allows easy access to the rapidly growing markets of the region. Its diverse population, comprising of Chinese, Malay, Indian, Eurasian and others, provides a broad genetic pool that is representative of Asia, making it ideal for clinical trials.
Ethnic mix of citizen population in Singapore (%)
*Data accurate as of Sep 2023 | Source: Population in Brief 2023
The Health Sciences Authority (HSA) of Singapore ensures that clinical trials meet the local requirement and regulation under the Health Products Act and the Medicines Act. The efficient and transparent regulatory process facilitates faster regulatory approval to conduct a clinical trial. For a comprehensive understanding of the regulatory framework for clinical trials in Singapore and HSA’s processes, kindly visit the official HSA website.
Singapore boasts state-of-the-art medical facilities and research institutions. This is evident from World Health Organization’s (WHO) high ranking of Singapore’s healthcare system, underscoring its efficiency, quality and positive health outcomes.
Singapore’s healthcare sector is strengthened by a robust workforce, with a favorable ratio of healthcare professional to the general public. The nation’s emphasis on medical education and continuous professional development ensures that its healthcare practitioners are well-equipped with the latest knowledge and skills.
Overview of Singapore’s Healthcare Professional-to-Population Ratio in 2022
2.8 Doctor
7.8 Nurse
0.5 Dentist
0.7 Pharmacist
0.5 Optometrist and Optician
As per 1000 population
*Data accurate as of Aug 2023 | Source: MOH | Health Manpower
Singapore is home to a thriving CRO landscape, guaranteeing comprehensive support for all clinical trials undertaken. Whether it is data management, patient recruitment or any other aspect of a clinical trial, sponsors can find a CRO with the specific expertise they need. For a comprehensive list of the CROs available in Singapore, please click here.
The Singapore government, through agencies like the Biomedical Research Council (BMRC) and the National Medical Research Council (NMRC), provides substantial funding for clinical research projects. These grants are designed to foster innovation, attract top talent and facilitate public-private partnership.